Mersana Therapeutics (MRSN) Receives a Buy from TD Cowen
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report). The company’s ...
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on ...
Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug ...
Yahoo Finance3d
Mersana Therapeutics, Inc. (MRSN)
Pre-Market: 5:02:04 a.m. EST Loading Chart for MRSN ...
Yahoo Finance6d
Mersana Therapeutics, Inc. (MRSN)
CDIO Cardio Diagnostics Holdings, Inc.
Yahoo Finance1d
X4 Pharmaceuticals, Inc. (XFOR)
After hours: 7:40:18 p.m. EST ...